
It took a while before pharma started to embrace the digital world as a (future) component of its go-to-market strategy, but in 2008, many companies finally started to get high-visibility strategic pr
(Jan 17, 2009)With the increasing short- and long-term pressures on pharma and the strategic focus on new business models, one would expect that new channels would be at least one of the key new tactics.
(May 9, 2009)Pharma companies moving digital mainstream
(May 31, 2011)Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Andrew Tolve investigates the opportunities and challenges for pharma’s use of cloud computing
Phil Taylor explores how pharma’s relationship to key opinion leaders is changing - for the better
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs